Carregant...
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-drug Conjugates
To enable antibodies to function as cytotoxic anticancer agents, they are modified either via attachment to protein toxins or highly potent small molecular weight drugs. Such molecules, termed immunotoxins and antibody drug conjugates respectively, represent a second revolution in antibody-mediated...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3201758/ https://ncbi.nlm.nih.gov/pubmed/21998010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-1374 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|